Volume 17, Number 6—June 2011
Dispatch
Increasing Ceftriaxone Resistance in Salmonellae, Taiwan
Table 1
Serotype and isolate (no. patients) | Year | Type of specimen | Susceptibility profile† | Puls‡ | Plasmid profile, kb§ | DNA–DNA hybridization¶ |
PCR sequencing# |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
spvC | rep FIIA/FIB | Rep_3 | gyrA |
parC |
|||||||||
Ser(83) | D(87) | Ser(80) | |||||||||||
Choleraesuis | |||||||||||||
SC-B67 | 2002 | Blood | R/R/R | C-1-a | 50, 138 | 50 | 50 | 138 | F | N | I | ||
SC-B104 (1) | 2003 | Blood | R/R/R | C-1-b | 50, 150 | 50 | 50 | 150 | F | N | I | ||
SC-B93 (2) | 2003 | Blood | R/R/R | C-1-b | 50, 115 | 50 | 50 | 50,115 | F | N | I | ||
SC-B98 (3) | 2004 | Blood | R/R/R | C-1-c | 50, 138 | 50 | 50 | 138 | F | N | I | ||
NA (4) | 2004 | Pus | R/R/R | NA | NA | NA | NA | NA | NA | NA | NA | ||
SC-B131 (5) | 2004 | Blood | R/R/R | C-1-d | 50, 138 | 50 | 50 | 138 | F | N | I | ||
SC-B132 (6) | 2004 | Blood | R/R/R | C-1-b | 50, 150 | 50 | 50 | 150 | F | N | I | ||
NA (7) | 2005 | Pus | R/S/R | NA | NA | NA | NA | NA | NA | NA | NA | ||
SC-B134 (8) | 2007 | Blood | R/S/R† | C-1-e | 40, 65, 105 | 65 | 65 | 40 | Ser | N | Ser | ||
SC-B136 (9) | 2008 | Blood | R/R/R | C-2 | 115, 138 | 115 | 115 | 115 | F | N | I | ||
NA (10) |
2009 |
Pus |
R/S/R |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
||
Typhimurium var. Copenhagen SB-5 |
2010 |
Feces |
R/R/R |
B-1-a |
7, 125, 180, 260 |
Neg |
Neg |
Neg |
Ser |
D |
Ser |
||
Typhimurium | |||||||||||||
SB-28 | 2010 | Urine | R/R/S | B-2 | 115, 210 | Neg | Neg | Neg | Ser | D | Ser | ||
SB-151 | 2010 | Feces | S/S/S | B-1-b | 85 | Neg | Neg | Neg | Ser | D | Ser | ||
SB-193 |
2010 |
Feces |
R/R/S |
B-2 |
105, 210 |
Neg |
Neg |
Neg |
Ser |
D |
Ser |
||
Agona SB-105 |
2010 |
Feces |
R/S/S |
B-3 |
95 |
Neg |
Neg |
Neg |
Ser |
D |
Ser |
||
Enteritidis SD-166 | 2010 | Feces | R/S/S | D-1 | 45, 60, 95 | 60 | Neg | Neg | Ser | D | Ser |
*Puls, pulsotype; R, resistant; F, phenylalanine; N, asparagine; I, isoleucine; NA, not available; S, susceptible; ser, serine; neg, negative reaction; var., variant; D, aspartic acid.
†Antimicrobial drug susceptibility to chloramphenicol, trimethoprim/sulfamethoxazole, and quinolones. Results were the same for the 2 quinolones (nalidixic acid and ciprofloxacin) tested, except that SC-B134 was resistant to nalidixic acid and susceptible to ciprofloxacin. All isolates were resistant to ampicillin and ceftriaxone.
‡Pulsed-field gel electrophoresis; pulsotypes are expressed as serogroup-major type-subtype.
§Plasmids harboring the blaCMY-2-carrying Tn6092 element are shown in boldface. IncI1 plasmids are underlined. Both are evidenced by DNA–DNA hybridization.
¶The size (kb) of the plasmid showing positive results in the respective DNA–DNA hybridization experiments is indicated. Rep_3, replicon of pSC138, the Tn6092-containing resistant plasmid of strain SC-B67.
#Amino acid changes compared with the quinolone resistance–determining regions of gyrA (codons 83 and 87) and parC (codon 80) in S. enterica
serotype Typhimurium LT2. No mutation was found in gyrB and parE.